test

Aryn Sands

@Bml Capital Management, Llc

Latest period2024 - Q3ReportedManaged Assets$169.95MTotal holdings29
Assets growth rate21.28%Assets growth rate (2-Q avg)6.84%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Bml Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 29 positions.

Assets under management

The assets under management (AUM) of Bml Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 169.95M in assets, with a quarterly growth rate of 21.28% and a 2-quarter average growth rate of 6.84%. The portfolio is managed by Aryn Sands, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ACHLAchilles Therapeutics Plc
Recent Activity
Increased 555.82%
2.47%
$4.182M
4.1M shares@ $1.02 avg price
AADIAadi Bioscience Inc
Recent Activity
New Position
2.43%
$4.12M
2M shares@ $2.06 avg price
CNTBConnect Biopharma Hldgs Ltd
Recent Activity
Increased 2.45%
1.78%
$3.014M
2.093M shares@ $1.44 avg price
PMVPPmv Pharmaceuticals Inc
Recent Activity
Increased 28.98%
1.49%
$2.516M
1.689M shares@ $1.49 avg price
ASTCAstrotech Corp
Recent Activity
1.04%
$1.761M
220,410 shares@ $8.0 avg price
MISTMilestone Pharmaceuticals In
Recent Activity
Increased 3.01%
1.02%
$1.727M
1.136M shares@ $1.52 avg price
LENZLenz Therapeutics Inc
Recent Activity
Decreased -6.12%
0.84%
$1.424M
60,000 shares@ $23.74 avg price
IKNAIkena Oncology Inc
Recent Activity
Increased 23.62%
0.74%
$1.251M
723,288 shares@ $1.73 avg price
VNDAVanda Pharmaceuticals Inc
Recent Activity
Decreased -42.62%
0.64%
$1.072M
228,500 shares@ $4.69 avg price
LSTALisata Therapeutics Inc
Recent Activity
0.51%
$854,007
284,669 shares@ $3.0 avg price